| Title |
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
|
|---|---|
| Published in |
Vascular Health and Risk Management, April 2012
|
| DOI | 10.2147/vhrm.s28744 |
| Pubmed ID | |
| Authors |
Julia Gaebler, Blickensderfer, Peskin, Soto-Campos, Hoogwerf, Han, Julia Gaebler, Alperin, Cohen, Wintle, Maggs, Pencek |
| Abstract |
Patients with type 2 diabetes (T2DM) are at risk of long-term vascular complications. In trials, exenatide once weekly (ExQW), a GLP-1R agonist, improved glycemia, weight, blood pressure (BP), and lipids in patients with T2DM. We simulated potential effects of ExQW on vascular complications, survival, and medical costs over 20 years versus standard therapies. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Luxembourg | 1 | <1% |
| Belgium | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 121 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 19% |
| Student > Master | 20 | 16% |
| Student > Ph. D. Student | 16 | 13% |
| Student > Bachelor | 12 | 10% |
| Other | 8 | 6% |
| Other | 16 | 13% |
| Unknown | 29 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 10% |
| Nursing and Health Professions | 10 | 8% |
| Agricultural and Biological Sciences | 9 | 7% |
| Unspecified | 3 | 2% |
| Other | 15 | 12% |
| Unknown | 33 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2018.
All research outputs
#6,823,235
of 25,584,565 outputs
Outputs from Vascular Health and Risk Management
#220
of 785 outputs
Outputs of similar age
#43,647
of 173,277 outputs
Outputs of similar age from Vascular Health and Risk Management
#3
of 14 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 785 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,277 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.